Argent BioPharma Dividend
Dividend criteria checks 0/6
Argent BioPharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -AU$0.38 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?
Jun 23
MGC Pharmaceuticals (ASX:MXC) Has Debt But No Earnings; Should You Worry?
Mar 09Auditors Have Doubts About MGC Pharmaceuticals (ASX:MXC)
Oct 08If You Had Bought MGC Pharmaceuticals (ASX:MXC) Shares A Year Ago You'd Have Earned 346% Returns
Feb 21
What Does MGC Pharmaceuticals' (ASX:MXC) CEO Pay Reveal?
Dec 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if RGT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if RGT's dividend payments have been increasing.
Dividend Yield vs Market
| Argent BioPharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RGT) | n/a |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.3% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast in 3 Years (RGT) | 0% |
Notable Dividend: Unable to evaluate RGT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate RGT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate RGT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as RGT has not reported any payouts.